QRG Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19M | Buy |
130,869
+1,439
| +1% | +$24.1K | 0.02% | 458 |
|
|
2025
Q1 | $1.99M | Sell |
129,430
-18,708
| -13% | -$288K | 0.02% | 454 |
|
|
2024
Q4 | $3.26M | Buy |
148,138
+5,556
| +4% | +$122K | 0.03% | 376 |
|
|
2024
Q3 | $2.57M | Sell |
142,582
-2,356
| -2% | -$42.5K | 0.03% | 406 |
|
|
2024
Q2 | $2.36M | Buy |
144,938
+1,191
| +0.8% | +$19.4K | 0.03% | 384 |
|
|
2024
Q1 | $2.03M | Buy |
143,747
+50,247
| +54% | +$709K | 0.03% | 416 |
|
|
2023
Q4 | $976K | Buy |
93,500
+8,680
| +10% | +$90.6K | 0.01% | 539 |
|
|
2023
Q3 | $865K | Buy |
+84,820
| New | +$865K | 0.02% | 522 |
|